ArticleBlood advances2022

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.

Cristina Pascual Izquierdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.